Article
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass.
The oncologist - 3 Oct 2024
Habringer Stefan, Ihlow Jana, Kleo Karsten, Klostermann Anna, Schmidt Max, Chai Lidan, Knödler Maren, Leyvraz Serge, Sigler Christian, Sinn Bruno, Maschmeyer Georg, Jegodka Yvette, Benary Manuela, Ott Claus-Eric, Tinhofer Ingeborg, Schäfer Reinhold, Möbs Markus, Keller Ulrich, Keilholz Ulrich, Rieke Damian T
Abstract excerpt
A patient with gastrointestinal stroma tumor (GIST) and KIT p.V559D and BRAF p.G469A alterations was referred to our institutional molecular tumor board (MTB) to discuss therapeutic implications. The patient had been diagnosed with B-cell chronic lymphocytic leukemia (CLL) years prior to the MTB presentation. GIST had been diagnosed 1 month earlier. After structured clinical annotation of the molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.